Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London midday: FTSE dips into the red; UK politics in focus
(Sharecast News) - London stocks had dipped into the red by midday on Monday as investors weighed the latest political developments in the UK against a surge in Japan's Nikkei, after prime minister Takaichi secured a landslide victory in Sunday's general election. The FTSE 100 was down 0.1% at 10,358.13.
Stocks had opened higher following strong gains in Asia, where the Nikkei jumped nearly 4% to close at a record high of 56,364 after Prime Minister Takaichi's Liberal Democratic party secured a two-thirds supermajority in the elections.
But the top-flight index had nudged into negative territory by midday, while UK government borrowing costs edged up and the pound fell against the US dollar after Prime Minister Keir Starmer's director of communications, Tim Allan resigned, a day after his chief of staff Morgan McSweeney.
The resignations came as the PM continued to suffer the fallout from his appointment of Peter Mandelson as ambassador to the US. McSweeney said on Sunday that he took "full responsibility" for advising the PM to appoint Mandelson, who is now facing a police investigation over his links to convicted sex offender Jeffrey Epstein.
Neil Wilson, UK investor strategist at Saxo Markets, said: "Far from drawing a line under things, this seems to have sparked renewed calls for Starmer to do the same. Gilts were steady enough Monday morning but if the bond vigilantes were to sniff the likelihood of a leadership change I'd expect gilts to sell off with sterling also hit as a proxy for investor sentiment towards UK political uncertainty and instability."
In equity markets, precious metals miner Fresnillo and gold miners Endeavour and Hochschild all shone as gold and silver prices rose.
Susannah Streeter, chief investment strategist at Wealth Club, said: "Gold has risen back above $5,000 as safe haven demand continues and investors take the opportunity to buy in as the dollar weakens again. The precious metal continues to be sought after by central banks, like the People's Bank of China which increased its purchases yet again in January."
Plus500 surged after saying its FY 2026 performance was set to be ahead of market expectations following a better-than-expected performance in 2025, as it announced "significant" shareholder returns.
Ocado was little changed following a report over the weekend that it's planning to cut up to 1,000 jobs, or 5% of its global headcount, as part of a renewed cost-cutting drive after a bruising year for its automated warehouse business. According to The Times, talks are still in their early stages and a final decision has yet to be made.
On the downside, NatWest slumped after saying it was buying UK wealth manager Evelyn Partners from funds advised by Permira and Warburg Pincus for £2.7bn and launching a new £750m share buyback. The bank said the deal would increase fee income by 20% pre-revenue synergies. Evelyn Partners has £69bn of assets under management.
Lloyds was also sharply lower.
Greggs was under the cosh after broker Jefferies downgraded the shares to 'hold' from 'buy' and slashed the price target to 1,610p from 2,500p, saying that weight-loss jabs could dent demand for the bakery chain's products.
"While investor concerns have typically focused on pricing and cannibalisation, we are increasingly of the view that the rapid uptake of GLP‑1 weight‑loss drugs is impacting Greggs," it said.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.